Charles River Laboratories to Present at Raymond James and Barclays Investor Conferences
WILMINGTON, Mass.--(BUSINESS WIRE)--Mar 4, 2019--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:
- Raymond James 40 th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 5 th, at 9:50 a.m. ET; and
- Barclays Global Healthcare Conference in Miami, Florida on Wednesday, March 13 th, at 10:15 a.m. ET.
Management will present an overview of Charles River’s strategic focus and business developments.
A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190304005055/en/
CONTACT: Todd Spencer
Corporate Vice President, Investor Relations
KEYWORD: UNITED STATES NORTH AMERICA FLORIDA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL GENERAL HEALTH
SOURCE: Charles River Laboratories International, Inc.
Copyright Business Wire 2019.
PUB: 03/04/2019 08:30 AM/DISC: 03/04/2019 08:30 AM